Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report

Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report

Burak Kulaksizoğlu,1,2 Hüseyin Kara,1,2 Berkan Bodur,1,2 Murat Kuloğlu1,2 1Department of Psychiatry, Akdeniz University School of Medicine, Antalya, Turkey; 2Akdeniz University, Alcohol and Substance Addiction Treatment and Research Center, Antalya, Turkey Abstract: Opioid misuse and depe...

Full description

Bibliographic Details
Main Authors:	Kulaksizoğlu B, Kara H, Bodur B, Kuloğlu M
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-11-01
Series:	Neuropsychiatric Disease and Treatment
Subjects:	intravenous buprenorphine-naloxone pregabalin drug misuse
Online Access:	https://www.dovepress.com/intravenous-buprenorphinenaloxone-and-concomitant-oral-pregabalin-misu-peer-reviewed-article-NDT

Similar Items

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
by: Hassan Ziaaddini, et al.
Published: (2018-12-01)

Pregabalin misuse in a 75-year-old woman
by: Avinash De Sousa
Published: (2019-01-01)

Pregabalin misuse: A silent epidemic
by: A. Hapangama, et al.
Published: (2019-12-01)

Epidural Naloxone to Prevent Buprenorphine Induced PONV
by: Ashok Jadon, et al.
Published: (2008-01-01)

Beneficial Effects of Opioid Rotation to Buprenorphine/Naloxone on Opioid Misuse, Craving, Mental Health, and Pain Control in Chronic Non-Cancer Pain Patients with Opioid Use Disorder
by: Arnt F. A. Schellekens, et al.
Published: (2021-08-01)

Sociodemographic and clinical characteristics of patients with long-term remission with buprenorphine / naloxone in opiate use disorder
by: Y. Kahya, et al.
Published: (2021-04-01)

Nasal pregabalin overdose and myclonus: a new way of misuse
by: H. Mihrimah Ozturk, et al.
Published: (2019-04-01)

Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial
by: Hannah Ellerbroek, et al.
Published: (2022-09-01)

Safety and Efficacy of Buprenorphine-Naloxone in Pregnancy: A Systematic Review of the Literature
by: Alice Ordean, et al.
Published: (2023-02-01)

Sublingual Buprenorphine/Naloxone and Multi-Modal Management for High-Risk Chronic Pain Patients
by: Shane Kaski, et al.
Published: (2021-03-01)

Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic
by: David Dadiomov, et al.
Published: (2022-06-01)

Oxybutynin treatment for buprenorphine-naloxone-induced hyperhidrosis
by: Lindsay McCormack, BA, et al.
Published: (2021-04-01)

Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
by: Yvette N. Martin, et al.
Published: (2019-05-01)

Pregabalin addiction caracteristics at oran: A cohort study
by: C. Yasmine, et al.
Published: (2021-04-01)

Management of buprenorphine/naloxone therapy in substances abuse consumers in prison: efficacy and safety
by: Felice A. Nava
Published: (2018-11-01)

Psychological barriers to tobacco cessation in Indian buprenorphine-naloxone maintained patients: A pilot study
by: Piyali Mandal, et al.
Published: (2015-01-01)

Treatment retention in opioid agonist therapy: comparison of methadone versus buprenorphine/naloxone by analysis of daily-witnessed dispensed medication in a Canadian Province
by: Joseph Sadek, et al.
Published: (2022-07-01)

Adapting low-dose buprenorphine induction to meet patient needs: A pilot study
by: Zoe A. Karavolis, et al.
Published: (2022-12-01)

A prospective randomized study to compare hemodynamic changes and post-operative outcome of intravenous buprenorphine versus epidural buprenorphine in patients undergoing abdominal surgeries under general anesthesia
by: Youvaraj M, et al.
Published: (2023-06-01)

Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design
by: Payel Jhoom Roy, et al.
Published: (2023-03-01)

Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
by: Jennifer Rozylo, et al.
Published: (2020-01-01)

Comparison of the risk of drop-out from opioid maintenance treatment in patients using naltrexone implants vs. oral buprenorphine-naloxone (tur)
by: Umut Kırlı, et al.
Published: (2021-09-01)

Prescribing trends of gabapentin, pregabalin, and oxycodone: a secondary analysis of primary care prescribing patterns in England
by: Katlyn Green, et al.
Published: (2019-09-01)

Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use
by: Erin L. Winstanley, et al.
Published: (2022-12-01)

Use of urinary naloxone levels in a single provider practice: a case study
by: Jill S. Warrington, et al.
Published: (2020-01-01)

Naloxone and Metabolites Quantification in Cord Blood of Prenatally Exposed Newborns and Correlations with Maternal Concentrations
by: Samantha L. Wiegand, et al.
Published: (2016-10-01)

Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
by: Katherin Badke, et al.
Published: (2024-02-01)

“Just give me pregabalin, doctor”: pregabalin use disorder in two undocumented migrants from North Africa
by: Catarina Cunha, et al.
Published: (2023-11-01)

Remote buprenorphine-naloxone initiation as an essential service for people with chronic pain and opioid dependence during the COVID-19 pandemic: Case reports, clinical pathways, and implications for the future
by: Hance Clarke, et al.
Published: (2020-01-01)

Comparative Trial to Study the Effectiveness of Clonidine Hydrochloride and Buprenorphine-Naloxone in Opioid Withdrawal – A Hospital Based Study
by: Syed Sajad Hussain, et al.
Published: (2015-01-01)

Population pharmacokinetics of buprenorphine and naloxone sublingual combination in Chinese healthy volunteers and patients with opioid use disorder: Model-based dose optimization
by: Meng Gu, et al.
Published: (2023-01-01)

Perioperative Pain Management for Median Sternotomy in a Patient on Chronic Buprenorphine/Naloxone Maintenance Therapy: Avoiding Opioids in Patients at Risk for Relapse
by: Alalade E, et al.
Published: (2020-02-01)

Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids
by: Payal H. Desai, PharmD, BCCCP, et al.
Published: (2021-07-01)

Successful conversion from butorphanol nasal spray to buprenorphine/naloxone using a low-dose regimen to assist with opioid tapering in the setting of chronic pain and migraine management in an older adult patient: A case report
by: Joshua MacAusland-Berg, et al.
Published: (2022-12-01)

Neuropsychological function is improved among opioid dependent adults who adhere to opiate agonist treatment with buprenorphine-naloxone: a preliminary study
by: Travis M. Scott, et al.
Published: (2017-11-01)

Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone
by: Lindsay M. Mailloux, PharmD, et al.
Published: (2021-01-01)

Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs
by: Travis M. Scott, et al.
Published: (2021-10-01)

From controlled opioid substitution treatment to pharmacy delivery of buprenorphine-naloxone and to treatment in primary health care: the views of patients and personnel
by: Jouni Tourunen, et al.
Published: (2010-12-01)

From controlled opioid substitution treatment to pharmacy delivery of buprenorphine-naloxone and to treatment in primary health care: the views of patients and personnel
by: Jouni Tourunen, et al.
Published: (2010-12-01)

Buprenorphine Exposure Alters the Development and Migration of Interneurons in the Cortex
by: Vanesa Nieto-Estévez, et al.
Published: (2022-05-01)